Variant report
Variant | nsv963286 |
---|---|
Chromosome Location | chr3:162941559-162967897 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr3:162946522-162946561 | GM20000 | blood: | n/a | n/a |
2 | CTCF | chr3:162953064-162953107 | Spleen_OC | spleen: | n/a | n/a |
3 | FOXA2 | chr3:162954899-162955485 | A549 | lung: | n/a | n/a |
4 | FOXA2 | chr3:162954989-162955392 | A549 | lung: | n/a | n/a |
5 | GATA3 | chr3:162946554-162946752 | SH-SY5Y | brain: | n/a | n/a |
6 | GATA3 | chr3:162965902-162966184 | SH-SY5Y | brain: | n/a | n/a |
7 | MAFK | chr3:162950725-162950744 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | MAFK | chr3:162945809-162945821 | K562 | blood: | n/a | chr3:162945810-162945821 |
9 | MYC | chr3:162963651-162963897 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr3:162942982-162943122 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr3:162951394-162951539 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr3:162960831-162960922 | Hela-S3 | cervix: | n/a | n/a |
13 | POLR2A | chr3:162942403-162942588 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr3:162960907-162961287 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr3:162963425-162963830 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr3:162964060-162964153 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | REST | chr3:162966087-162966490 | ECC-1 | luminal epithelium: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
18 | REST | chr3:162966121-162966521 | PANC-1 | pancreas: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
19 | REST | chr3:162966169-162966363 | Hela-S3 | cervix: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
20 | REST | chr3:162966086-162966488 | HL-60 | blood: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
21 | REST | chr3:162966127-162966428 | MCF-7 | breast: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:162965564..162967593-chr3:162971986..162973917,2 | K562 | blood: |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OTOL1-2 | chr3:162946486-162946540 | ENSG00000241168.1 |
2 | lnc-OTOL1-2 | chr3:162948497-162949937 | ENSG00000241168.1 |
3 | lnc-OTOL1-2 | chr3:162948497-162949934 | NONHSAT093026 |
4 | lnc-OTOL1-2 | chr3:162946486-162946540 | NONHSAT093026 |
5 | lnc-SI-4 | chr3:162967053-162967162 | ENSG00000241369 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CT64 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149789399 | chr3:162941635-162941636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556997872 | chr3:162941665-162941666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145767068 | chr3:162941678-162941679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184873966 | chr3:162941681-162941682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540908156 | chr3:162941762-162941763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563357577 | chr3:162941844-162941845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1994750 | chr3:162941903-162941904 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs148969229 | chr3:162941918-162941919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549599468 | chr3:162941935-162941936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374954853 | chr3:162941936-162941937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189233026 | chr3:162941960-162941961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530360294 | chr3:162942013-162942014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35645329 | chr3:162942028-162942029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181529648 | chr3:162942034-162942035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536565893 | chr3:162942062-162942063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571327067 | chr3:162942102-162942103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145838306 | chr3:162942144-162942145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552830266 | chr3:162942165-162942166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371716727 | chr3:162942175-162942176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138469270 | chr3:162942203-162942204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141455417 | chr3:162942223-162942224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533347112 | chr3:162942228-162942229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555548602 | chr3:162942241-162942242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575217683 | chr3:162942299-162942300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544347684 | chr3:162942320-162942321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73013506 | chr3:162942322-162942323 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs577697222 | chr3:162942342-162942343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2035871 | chr3:162942351-162942352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs148183961 | chr3:162942433-162942434 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs372792681 | chr3:162942475-162942476 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs184996108 | chr3:162942477-162942478 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs375230709 | chr3:162942489-162942490 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs369512424 | chr3:162942573-162942574 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs111386455 | chr3:162942591-162942592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373973828 | chr3:162942723-162942724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563112157 | chr3:162942725-162942726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531663931 | chr3:162942771-162942772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530953832 | chr3:162942805-162942806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs367998739 | chr3:162942828-162942829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552142052 | chr3:162942831-162942832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35108258 | chr3:162942841-162942842 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs1873644 | chr3:162942905-162942906 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs6786504 | chr3:162942993-162942994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180906538 | chr3:162942995-162942996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544235848 | chr3:162943059-162943060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150732294 | chr3:162943184-162943185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138005445 | chr3:162943229-162943230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185760215 | chr3:162943246-162943247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143622084 | chr3:162943255-162943256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538073800 | chr3:162943288-162943289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162936400-162950200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
2 | chr3:162947400-162954200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:162953800-162954800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr3:162954200-162954800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
5 | chr3:162954200-162954800 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |